Financial statements Danfarm Med
Balance sheet data of DANFARM MED
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 715 719,15 | 713 688,93 | 739 307,68 | 906 557,43 | 1 901 164,70 | 2 442 414,89 |
| A. Fixed assets | 265 956,36 | 133 278,33 | 39 256,05 | 226 448,00 | 1 163 500,41 | 1 540 851,08 |
| B. Current assets | 449 762,79 | 580 410,60 | 700 051,63 | 680 109,43 | 737 664,29 | 901 563,81 |
| C. Share capital contributions (basic funds) | 0,00 | - | - | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | - | - | 0,00 | 0,00 | 0,00 |
| Total liabilities | 715 719,15 | 713 688,93 | 739 307,68 | 906 557,43 | 1 901 164,70 | 2 442 414,89 |
| A. Equity | 159 584,22 | 184 888,84 | 200 498,25 | 579 513,84 | 764 248,76 | 1 033 821,37 |
| B. Liabilities and provisions for liabilities | 556 134,93 | 528 800,09 | 538 809,43 | 327 043,59 | 1 136 915,94 | 1 408 593,52 |
| I. Long-term liabilities | - | 520 000,00 | 460 000,00 | 136 607,75 | 439 250,86 | 609 403,74 |
| II. Short-term liabilities | - | 8 800,09 | 78 809,43 | 190 435,84 | 645 347,92 | 799 189,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.